about
Transmissible Spongiform Encephalopathies Affecting HumansLentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected miceEffective gene therapy in a mouse model of prion diseasesEffects of beta-sheet breaker peptide polymers on scrapie-infected mouse neuroblastoma cells and their affinities to prion protein fragment PrP(81-145).The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob diseaseParacrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodiesWhat is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired?Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.Antiprion immunotherapy: to suppress or to stimulate?Rational targeting for prion therapeutics.Inhibition of PrP(Sc) formation in scrapie infected N2a cells by 5,7,8-trimethyl-3,4-dihydro-2H-1,4-benzoxazine derivatives.Antiprion prophylaxis by gene transfer of a soluble prion antagonist.Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection.Biochemical aspects of dementias.Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects.RNAi: a novel strategy for the treatment of prion diseases.Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers.Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion
P2860
Q24549130-038CC2EB-0446-4EF9-89FB-6A2D929FE450Q24673105-80DB862C-D287-4485-9595-22DDDCFFF6A5Q27300832-5B31E44C-4974-458B-AD70-9C010FDE5343Q30979178-E3E5E8EA-A536-4D68-8C8F-B29F8E870218Q33649832-10578093-3725-4A1E-9695-08955595ADFDQ33843281-0BBCE69B-0F41-4F16-ACB7-3AC23A6622F1Q34534616-812402F2-E24B-4D71-9B6E-B46ADA043B3AQ35714147-640BB8BB-43C3-40A8-AFEC-48AA905C6B1DQ35877214-6C05B72B-1C9E-460F-BF35-76D0FBA18B3DQ35990277-437E94CF-CABC-424D-AF68-42FC6426C2F8Q36436176-124AB439-950F-4366-8EDB-7E96A2318967Q36579822-5DA7FACF-DABD-4556-B380-860BA2656BB1Q37569845-23D526E0-A24B-4F66-AC22-8CC3573451DDQ38579674-3C3B469E-FFE2-491C-B57C-0C622F8A3E65Q40066046-DAD8694A-5FDD-45F7-A663-9F1E05ED0C66Q40201448-54B80314-F716-42BC-AD53-027D80863D65Q45140134-210763BA-B498-4D48-B60D-7D234877D33BQ57083661-74FF3293-5D66-4727-BFD4-CCBBB32D2FEF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Interventional strategies against prion diseases.
@ast
Interventional strategies against prion diseases.
@en
Interventional strategies against prion diseases.
@nl
type
label
Interventional strategies against prion diseases.
@ast
Interventional strategies against prion diseases.
@en
Interventional strategies against prion diseases.
@nl
prefLabel
Interventional strategies against prion diseases.
@ast
Interventional strategies against prion diseases.
@en
Interventional strategies against prion diseases.
@nl
P2093
P2860
P356
P1476
Interventional strategies against prion diseases.
@en
P2093
P2860
P2888
P304
P356
10.1038/35094590
P407
P577
2001-10-01T00:00:00Z
P6179
1033326084